The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Poukalov Konstantin since 2016.
This trader's CIK number is 1678736.
At the time of last reporting, Poukalov Konstantin was the Director of Landos Biopharma, Inc.. (stock ticker symbol LABP).
Also see all insider trading activities at Landos Biopharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | KDMN | 4,000 | $23,252 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | LABP | 1,500,187 | $23,239,400 | 0 | $0 | 0 | $0 |
1. Kadmon Holdings, Inc. (KDMN)
2. Landos Biopharma, Inc. (LABP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-11-11 | KDMN | Buy | 4,000 | 5.81 | 23,252 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-09 | LABP | Buy | 99,681 | 14.20 | 1,415,470 |
| 2021-02-08 | LABP | Buy | 123,053 | 12.34 | 1,518,104 |
| 2021-02-05 | LABP | Buy | 27,453 | 11.14 | 305,826 |
| 2021-02-08 | LABP | Buy | 1,250,000 | 16.00 | 20,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Poukalov Konstantin (Director of Landos Biopharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.